GlaxoSmithKline plc is seeking a partner to transform a third of its R&D site in Stevenage, UK, in a move that would create one of Europe’s largest life science campuses and raise £400m for the drugs major.
As part of proposals set out on 16 July, GSK is looking to sell 33 acres of land, with an aim to "unlock up to £400m in new investment from a private sector developer to build the new campus and potentially create up to 5,000 highly skilled jobs, over the next five to ten years